COVID-19: research / briefings / evidence (links)

First published: 22/05/2020 | Last updated: October 15th, 2020

For a thorough summary of addiction-related COVID-19 studies, see the Addiction Journal Bibliography. This provides a downloadable document listing articles found in PubMed involving addiction-related topics and COVID-19. It is updated weekly and all publications prior to January 2020 are removed.


Research / Briefings / Evidence A-Z

Addiction Journal: Bibliography on COVID-19 and addiction: click here

Addiction Journal: COVID‐19, smoking, vaping and quitting: a representative population survey in England

Alcohol and Alcoholism, Alcohol and COVID-19 editorial

Alcohol & Drug Foundation, Australia -‘ Changing your drinking habits’ find out about the six signs that home isolation could be impacting your drinking: click here

ADFAM: Families in Lockdown: The effects of the COVID-19 lockdown on the family and friends of someone with an alcohol, drug or gambling problem survey report

ASH Scotland Covid-19 and smoking research –a list of published articles on scientific research which includes information or data on smoking, nicotine and Covid-19.

Australian National University report ‘Alcohol consumption during the COVID-19 period’ shows Australians are drinking alcohol more frequently during the COVID-19 pandemic than before

British Columbia Centre on Substance Use (Canada) COVID-19 resources: click here

BMJ Global Health: YouTube as a source of information on COVID-19: a pandemic of misinformation?

BMJ Tobacco Control: COVID-19 and smoking: resources, research and news updated 9 Sept: click here

BMJ Tobacco Control: resources, research and news about COVID-19 and smoking, vaping and other tobacco products: click here

BJGP Open is rapidly publishing research and editorials on COVID-19, and will be collecting all articles here 

Brief Addiction Science Information Source (BASIS) The WAGER, Vol. 25(8):– Gambling in the time of COVID-19: Mental health, substance use, and financial distress among high-risk online gamblers

Bristol Drugs Project: Researching During A Pandemic -working with the Universities of Bristol and Bath to find out how the Coronavirus pandemic has affected the lives of people who inject drugs in Bristol.

Bristol Drugs Project COVID-19 Impact Report

Campaign for Social Science: Dr Hannah Carver and Dr Tessa Parkes, Faculty of Social Sciences, University of Stirling on how social science inspires researchers to create much needed system and service change for people who are homeless with substance use problems

Canadian Centre on Drug Use and Addiction: Impacts of the COVID-19 Pandemic on People Who Use Substances: What we have heard

Canadian Centre on Drug Use and Addiction (CCSA – in French & English): open versus closed: the risks associated with retail liquor stores during COVID-19click here

Canadian Centre on Drug Use and Addiction (CCSA) report: COVID-19 and cannabis smoking and vaping: four things you should know: click here

Canadian Centre on Drug Use and Addiction (CCSA): changes related to COVID-19 in the illegal drug supply and access to services, and resulting health harms (CCENDU Alert)

Canadian Centre on Substance Use and Addiction (CCSA): Boredom and Stress Drives Increased Alcohol Consumption during COVID-19: NANOS Poll Summary Report

Center de recherche du Center hospitalier de l’Université de Montréal (CRCHUM) Q&A: COVID-19 is worse for drug users

Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report :Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States MMWR Morb Mortal Wkly Rep 2020;69:1049–1057.

Cochrane Clinical Answers related to COVID-19 including CCAs (free) on effective options for quitting smoking during the pandemic: click here

Drug and Alcohol Dependence: COVID-19 survey among people who use drugs in three cities in Norway: short communication

Drug and Alcohol Research Connections – May 2020 – latest news from NDARC, NDRI and NCETA, with a special COVID-19 focus in this issue

Drug and Alcohol Review: The impact of nationwide alcohol ban during the COVID‐19 lockdown on alcohol use‐related internet searches and behaviour in India: An infodemiology study

DrugNet Ireland: Health Research Board Evidence brief on the response of drug services to Covid-19

Drugs and Me –Preliminary Survey Results how has drug use changed during the pandemic

EMCDDA report: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries

EMCDDA trendspotter briefing: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries

EMCDDA special report: COVID-19 and drugs – drug supply via darknet markets: click here

EMCDDA COVID-19: New study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

Fare Australia: family violence and alcohol during COVID-19

Foundation for Alcohol Research and Education (FARE) survey shows that 20% of Australians purchased more alcohol and 70% of them are drinking more alcohol than normal, with one third now using alcohol daily during the COVID-19 pandemic: click here

Frontiers in Psychiatry: Research Topic ‘Drug and Behavioral Addictions During Social-Distancing for the COVID-19 Pandemic’ series of eight papers.

Future of Personal Health: The Implications for Individuals with Substance Use Disorders during COVID-19 by Nora Volkow, Director of NIDA click here

Gambling Commission : Gambling business data updated during COVID-19

Global Drug Survey COVID-19 Special Edition: Key Findings Report

Health Research Board Library newsletter containing Irish and international resources on COVID-19: click here

House of Commons Nitrous Oxide: Coronavirus Parliamentary Question asking the Secretary of State for the Home Department what assessment has been made of the change in the level of the use of nitrous oxide during the covid-19 outbreak.

Imperial College London: a report on the global impact of COVID-19: click here

INPUD COVID-19 Survey Report 1: Health & Rights of People who Use Drugs in a COVID-19 Environment

International Journal of Drug Policy – Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets

Institute of Alcohol Studies: Alcohol consumption during the COVID19 lockdown: summary of emerging evidence from the UK

Institute of Alcohol Studies: Alcohol harms: a hidden pandemic in the age of COVID-19? 2nd briefing on alcohol consumption

Irish Journal Psychological Medicine: Addiction Psychiatry and COVID-19 – Impact on patients and service provision

JAMA Changes in Adult Alcohol Use and Consequences during the COVID-19 Pandemic in the US Research Letter

JAMA Psychiatry Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019 Recommendations to Enhance AdoptionViewpoint

Journal of Addictive Diseases: The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States

Journal of Epidemiology and Community Health Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study

Journal of Public Health -Threatening increase in alcohol consumption in physicians quarantined due to coronavirus outbreak in Poland: the ALCOVID survey

La Trobe University: A timeline of alcohol-relevant restrictions during the COVID-19 pandemic

London School of Economics: Illicit Drugs during Covid-19 -how has COVID-19 affected some of the most vulnerable people in society? | LSE Research

London School of Economics: Ireland’s innovative approach to supporting homeless and drug using populations during COVID-19 saved lives

NIDA Substance use disorders linked to COVID-19 susceptibility

NIDA Directors Blog ‘New Evidence on Substance Use Disorders and COVID-19 Susceptibility’

NIHR Applied Research Collaboration West: Understanding the experiences of people who inject drugs during the COVID-19 pandemic – findings from the LUCID-B study

National Association for Children of Alcoholics report: ‘Covid So Far, Lockdown and the Lost Children’ reports rise in calls from children whose parents have started to drink again in lockdown

National Drug and Alcohol Research Centre, UNSW Australia, research response to COVID-19: click here

National Drug and Alcohol Research Centre: Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020

National Drug and Alcohol Research Centre Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study

National Drug and Alcohol Research Centre: Have COVID-19 restrictions affected needle and syringe program transactions in Tasmania

Observatoire Français des Drogues et des Toxicomanies English summary of the 2nd OFDT-TREND bulletin examining changes caused by the COVID-19 pandemic and the lockdown measures in France to practices of drug users, drug services and drug trafficking

Pharmaceuticals Journal: Substance use disorder in the COVID-19 pandemic Systematic review of vulnerabilities and complications

Progress in Neuro-Psychopharmacology and Biological Psychiatry: Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review (in press)

Public Health England (PHE): emerging evidence from China shows smokers with COVID-19 are 14 times more likely to develop severe respiratory disease: click here

PHE: Wider Impacts of COVID-19 on Health (WICH) monitoring tool: PHE health intelligence teams are scoping metrics that will enable the monitoring of the indirect health impacts of COVID-19. Includes alcohol consumption, smoking and  updated with behavioural Risk Factors – smoking quit attempts and methods to support quitting, from the Smoking Toolkit Study.

PHE Wider Impacts of COVID on Health (WICH) tool now includes data on gambling behaviour pre&post lockdown.

Qeios: ‘Smoking, vaping and hospitalization for COVID-19’: click here

Qeios: The association of smoking status with SARS‐CoV‐2 infection, hospitalisation and mortality from COVID‐19: A living rapid evidence review with Bayesian meta‐analyses (version 7)

Release: Impact of Coronavirus on Drug Purchases Survey

Royal College of Psychiatrists: Addiction services not equipped to treat the 8 million people drinking at high risk during pandemic –press release

Russell Webster: Impact of coronavirus on drug use across Europe summary of the European Monitoring Centre for Drugs and Drug Addiction trendspotter study on the impact of Covid-19 on drug consumption patterns and drug-related harms

St George’s University of London: Smoking and obesity identified to have causal link with susceptibility to severe COVID-19 and sepsis

The Conversation Australia : Pot, pills and the pandemic: how coronavirus is changing the way we use drugs

The Global Drug Survey (GDS) Special Edition  report on COVID-19 highlights preliminary findings halfway through data collection. A complete report based on all data collected until June 20, 2020 follows in July | GDS, UK

The Lancet has created a COVID-19 resource centre. This resource brings together content from across The Lancet journals as it is published and is free to access: click here

The Lancet Gastroenterology & Hepatology -Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder

The Lancet Psychiatry: public health messaging and harm reduction in the time of COVID-19: click here

The Lancet Psychiatry: innovative strategies to support physical distancing among individuals with active addiction

The Lancet Respiratory Medicine: Tobacco smoking and COVID-19 infection

Toxicology Reports: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Editorial

UK parliament: call for experts from the Knowledge Exchange Unit: click here

UK Research and Innovation (UKRI): COVID-19, the science explained. This website will be regularly updated with the latest science information behind the COVID-19 outbreak: click here

UNODC Research Brief: COVID-19 and the drug supply chain: from production and trafficking to use

UNODC Research Brief COVID-19-related Trafficking of Medical Products as a Threat to Public Health

University College Cork researchers on ‘Why drug dealing and drug use will increase after Covid-19’

University College London study into the psychological and social effects of COVID-19: click here

University of Glasgow MRC/CSO Social and Public Health Sciences Unit: Alcohol use increased during lockdown, but smoking declined – sharing evidence  

University of Oxford researchers studying the effect of smoking, nicotine and vaping on COVID-19 severity inking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease

University of Queensland Research: COVID-19 cocktails: push for tighter alcohol advertising restrictions on social media

World Health Organisation (WHO) COVID-19 database – the latest scientific findings and knowledge on COVID-19. The global literature cited in the database is updated daily: click here

WHO and EMRO Q&A on tobacco, waterpipe and e-cigarette use in the context of COVID-19 (English and Arabic): click here

WHO Scientific Brief Smoking and COVID-19 click here

The SSA does not endorse nor guarantee the accuracy of the information in external sources or links, and accepts no responsibility or liability for any consequences arising from the use of such information

Every effort is made to maintain the accuracy of the information on the SSA website. However, things change all the time. If you discover any out-of-date links or if you know of other links that could be included, please let us know.